You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Velcade-melphalan-prednisone

Showing 51 - 75 of 1,641
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nephrotic Syndrome in Children Trial (Huaiqihuang granule, Prednisone, Levamisole )

Not yet recruiting
  • Nephrotic Syndrome in Children
  • Huaiqihuang granule
  • +4 more
  • (no location specified)
Mar 6, 2023

Multiple Myeloma Trial in Wuhan (Total Marrow irradiation,TMI, Autologous hematopoietic stem cell transplantation)

Recruiting
  • Multiple Myeloma
  • Total Marrow irradiation，TMI
  • Autologous hematopoietic stem cell transplantation
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 24, 2023

In-stent Restenosis Trial in Beijing (Colchicine, Prednisone, Aspirin)

Not yet recruiting
  • In-stent Restenosis
  • Beijing, Beijing, China
    Fuwai Hospital
Oct 15, 2023

Multiple Myeloma, Chronic Kidney Disease Trial in United Kingdom (Bortezomib, Thalidomide, Bendamustine)

Completed
Has Results
  • Multiple Myeloma
  • Chronic Kidney Disease
  • Basingstoke, United Kingdom
  • +8 more
Jan 26, 2022

Multiple Myeloma Trial in Tampa (Bortezomib, Melphalan, Autologous Stem Cell Transplant)

Completed
Has Results
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center
Aug 27, 2019

Multiple Myeloma Trial in Saint Louis (Uproleselan, Placebo, Melphalan)

Completed
  • Multiple Myeloma
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 22, 2022

Multiple Myeloma, First Relapse Trial in France (PCD, Autologous transplantation (ASCT))

Active, not recruiting
  • Multiple Myeloma
  • First Relapse
  • PCD
  • Autologous transplantation (ASCT)
  • Amiens, France
  • +29 more
Jul 13, 2022

Vasectomy Reversal Trial in Orem (Prednisone)

Recruiting
  • Vasectomy Reversal
  • Orem, Utah
    Cure PD
Jul 19, 2022

Taste Function In Multiple Myeloma Patients Undergoing

Active, not recruiting
  • Multiple Myeloma
  • Oral microbiota assessment
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Langerhans Cell Histiocytosis of Bone Trial in Shanghai (Prednisone)

Recruiting
  • Langerhans Cell Histiocytosis of Bone
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Oct 15, 2023

Multiple Myeloma, Myeloma Trial in Poitiers (Isatuximab, Lenalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Myeloma
  • Poitiers, France
    CHU Poitiers
Sep 5, 2022

Peripheral T Cell Lymphoma Trial (CHOP+selinexor+5-Azacitidine, CHOP+duvelisib+5-Azacitidine, CHOP+chidamide+tislelizumab)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • (no location specified)
Dec 29, 2022

Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)

Recruiting
  • Lymphoma
  • +4 more
  • Pharmacokinetics
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 12, 2022

Metastatic Prostate Cancer Trial in Worldwide (Ipatasertib, Abiraterone, Placebo)

Active, not recruiting
  • Metastatic Prostate Cancer
  • Chandler, Arizona
  • +183 more
Nov 24, 2022

Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,

Not yet recruiting
  • Androgen-Independent Prostatic Cancer
  • +8 more
  • lorigerlimab
  • +2 more
  • (no location specified)
May 4, 2023

Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (lenalidomide, Placebo, Rituximab)

Completed
Has Results
  • Lymphoma, Large B-Cell, Diffuse
  • Fayetteville, Arkansas
  • +431 more
Nov 17, 2022

Prostatic Tumors Trial in Bronx (Abiraterone Acetate, Prednisone)

Active, not recruiting
  • Prostatic Neoplasms
  • Bronx, New York
    Montefiore Medical Center
Sep 22, 2022

Hematologic Malignancies Trial in Minneapolis (Haplo HCT <55 years old, Haplo HCT =55 years old, GVHD Prophylaxis)

Recruiting
  • Hematologic Malignancies
  • Haplo HCT <55 years old
  • +4 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 25, 2023

Newly Diagnosed Multiple Myeloma Trial in Spain (Lenalidomide., Carfilzomib, Bortezomib)

Recruiting
  • Newly Diagnosed Multiple Myeloma
  • A Coruña, Spain
  • +64 more
Mar 12, 2021

Prostate Cancer Trial in Worldwide (Abiraterone, Apitolisib, Ipatasertib)

Completed
  • Prostate Cancer
  • Scottsdale, Arizona
  • +58 more
Sep 7, 2022

Metastatic Castrate Sensitive Prostate Cancer Trial in Worldwide (Niraparib, Abiraterone acetate (AA), Prednisone)

Recruiting
  • Metastatic Castrate Sensitive Prostate Cancer
  • Homewood, Alabama
  • +439 more
Jan 17, 2023

Retinoblastoma Trial in Saint Louis (Melphalan)

Active, not recruiting
  • Retinoblastoma
  • Saint Louis, Missouri
    Washington University School of Medicine (Saint Louis Children's
Jan 6, 2023

Retinoblastoma Trial in France (Melphalan or Melphalan + Topotecan, etoposide, carboplatin and vincristine, Carboplatin

Recruiting
  • Retinoblastoma
  • Melphalan or Melphalan + Topotecan
  • +6 more
  • Saint-Denis, La Réunion, France
  • +27 more
Nov 24, 2022

Uveal Melanoma Trial in Ribeirão Preto (Melphalan Injection, Plaque brachytherapy)

Enrolling by invitation
  • Uveal Melanoma
  • Melphalan Injection
  • Plaque brachytherapy
  • Ribeirão Preto, SP, Brazil
    Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto
May 29, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Jan 12, 2023